← Filing reader

KO — filing

0001628280-26-050503 · 250,765 characters of text, split into 1 sections

Filed with the SEC · open the original

Risk factors

Item 1A. Risk Factors

What to look forWhat management is required to admit could go wrong. Written by lawyers, but the ordering and any newly added risk are informative.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2025, which could materially affect our business, financial condition or future results. The risks described in this report and in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, could also materially adversely affect our business, financial condition or future result s.

48

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table presents information with respect to purchases of common stock of the Company made during the three months ended July 3, 2026 by the Company or any "affiliated purchaser" of the Company as defined in Rule 10b-18(a)(3) under the Exchange Act:

Period Total Number of Shares Purchased 1

Average

Price Paid

Per Share Total Number of

Shares Purchased as Part of the Publicly

Announced Plan 2

Maximum Number

of Shares That May

Yet Be Purchased

Under the Publicly

Announced Plan

April 4, 2026 through May 1, 2026 1,093,205 $ 76.63 1,085,577 60,981,263

May 2, 2026 through May 29, 2026 528,481 79.95 525,800 60,455,463

May 30, 2026 through July 3, 2026 772,808 80.23 770,349 59,685,114

Total 2,394,494 $ 78.53 2,381,726

1 The total number of shares purchased includes: (1) shares purchased, if any, pursuant to the plan described in footnote 2 below and (2) shares surrendered, if any, to the Company to pay the exercise price and/or to satisfy tax withholding obligations in connection with stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees.

2 In February 2019, the Company publicly announced that our Board of Directors had authorized a plan ("2019 Plan") for the Company to purchase up to 150 million shares of our common stock. This column discloses the number of shares purchased, if any, pursuant to the 2019 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading plans meeting the requirements of Rule 10b5-1 under the Exchange Act).

Item 5. Other Information

During the fiscal quarter ended July 3, 2026, none of our Directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408 of Regulation S-K.

Item 6. Exhibits

In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements contain representations, warranties, covenants and conditions by or of each of the parties to the applicable agreement. These representations, warranties, covenants and conditions have been made solely for the benefit of the other parties to the applicable agreement and:

Excerpt. This section runs to 17,401 characters — read the whole filing at the SEC.

Not found in this filing

Business, Legal proceedings, Market for the shares, Management's discussion, Market risk, Financial statements. Filers format their reports differently, and this reader would rather say it could not find a section than show you the wrong one.

Educational material, not investment advice. Nothing here is a recommendation to buy or sell anything.